Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging
Cell Stem Cell · 2024-08 · 31 (8) · 1127-1144.e17
DOI: 10.1016/j.stem.2024.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2024-08. Verfasst von Niels Asger Jakobsen und 29 weiteren Autor:innen. Beteiligte Einrichtung: MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK; Oxford Centre for Haematology, NIHR…. Hauptthemen laut MEDLINE: Inflammation, Aging, Clonal Hematopoiesis, Mutation. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Radcliffe Department of Medicine, University of Oxford, Blood Cancer UK.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK; Oxford Centre for Haematology, NIHR Oxford Biomedical Research Centre, Oxford, UK.
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
- MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
- MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK; Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Ox…
Förderung
- Medical Research Council
- Radcliffe Department of Medicine, University of Oxford
- Blood Cancer UK
- Government of Ontario
- Manchester Biomedical Research Centre
- Pfizer
- Terry Fox Foundation
- Clarendon Fund
Zitieren
APA
Jakobsen, N. A., Turkalj, S., Zeng, A. G. X., Stoilova, B., Metzner, M., Rahmig, S., Nagree, M. S., Shah, S., Moore, R., Usukhbayar, B., Angulo Salazar, M., Gafencu, G. A., Kennedy, A., Newman, S., Kendrick, B. J. L., Taylor, A. H., Afinowi-Luitz, R., Gundle, R., Watkins, B., …, & Vyas, P. (2024). Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging. Cell Stem Cell, 31(8), 1127-1144.e17. https://doi.org/10.1016/j.stem.2024.05.010
Vancouver
Jakobsen NA, Turkalj S, Zeng AGX, Stoilova B, Metzner M, Rahmig S, et al. Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging. Cell Stem Cell. 2024;31(8):1127-1144.e17. doi:10.1016/j.stem.2024.05.010
BibTeX
@article{Jakobsen2024,
author = {Jakobsen, Niels Asger and Turkalj, Sven and Zeng, Andy G X and Stoilova, Bilyana and Metzner, Marlen and Rahmig, Susann and Nagree, Murtaza S and Shah, Sayyam and Moore, Rachel and Usukhbayar, Batchimeg and Angulo Salazar, Mirian and Gafencu, Grigore-Aristide and Kennedy, Alison and Newman, Simon and Kendrick, Benjamin J L and Taylor, Adrian H and Afinowi-Luitz, Rasheed and Gundle, Roger and Watkins, Bridget and Wheway, Kim and Beazley, Debra and Murison, Alex and Aguilar-Navarro, Alicia G and Flores-Figueroa, Eugenia and Dakin, Stephanie G and Carr, Andrew J and Nerlov, Claus and Dick, John E and Xie, Stephanie Z and Vyas, Paresh},
title = {Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging},
journal = {Cell Stem Cell},
year = {2024},
volume = {31},
number = {8},
pages = {1127--1144.e17},
doi = {10.1016/j.stem.2024.05.010}
}
EUVIMED